The new
DUOLITH® SD1 T-TOP ultra+
Focused shock wave therapy –
Efficient, effective and gentle
The new
DUOLITH® SD1 T-TOP ultra+
Evidence-based shock wave therapy –
from the interdisciplinary market leader STORZ MEDICAL
STORZ MEDICAL is the world-leading provider of shock wave therapy. Our company has been developing and producing high-precision non-invasive therapy systems in Switzerland since 1987. A pioneer of medical technology, Dr Karl Storz was the initiator and driving force behind the creation of STORZ MEDICAL AG.
Our shock wave devices and therapy systems have proven themselves millions of times over, particularly in urology for the treatment of kidney and ureteral stones using Extracorporeal Shock Wave Lithotripsy (SWL). Today, non-invasive shock wave technology has become an essential part of many medical disciplines: as a world-leading provider of Extracorporeal Shock Wave Therapy (ESWT) and Extracorporeal Shock Wave Lithotripsy (SWL), STORZ MEDICAL develops high-precision shock wave devices, therapy systems and state-of-the-art lithotripters for urology, orthopaedics, sports medicine, cardiology, neurology, dermatology and veterinary medicine.
Extracorporeal Shock Wave Lithotripsy (SWL) for stone diseases
Extracorporeal Shock Wave Therapy (ESWT) for CPPS/IPP/ED
Extracorporeal Shock Wave Therapy (ESWT) for musculoskeletal disorders
Extracorporeal Magnetotransduction Therapy (EMTT) for musculoskeletal disorders
Transcranial Pulse Stimulation (TPS) for treatment of patients with Alzheimer’s disease
Cardiac Shock Wave Therapy (CSWT) for the treatment of ischemic heart disease, coronary heart disease and angina pectoris
Acoustic Wave Treatment (AWT®) for aesthetic indications
Extracorporeal Shock Wave Therapy (ESWT) for wound healing
Extracorporeal Shock Wave Therapy (ESWT) for veterinary medicine
Our therapy solutions cover both focused shock wave therapy and radial shock wave therapy to treat a wide range of medical indications effectively. In addition, STORZ MEDICAL offers vibration therapy using the V-ACTOR® for massage and muscular stimulation, among other applications. Our therapies are evidence-based, clinically proven and are an established part of clinical practice in over 130 countries around the world.
We set standards: STORZ MEDICAL was the first company to successfully use Cardiac Shock Wave Therapy (CSWT) in myocardial revascularisation and to develop a new non-invasive form of therapy for patients with Alzheimer’s disease using Transcranial Pulse Stimulation (TPS). We develop our therapies in close collaboration with university research centres and hospitals across Europe.
Our devices have certifications from around the world, including CE, MDSAP and FDA. The MODULITH® SLX-F2 is approved in the USA by the FDA for the treatment of kidney and ureteral stones in children aged over 3 years.
As an innovation-driven company, we are continuously developing new non-invasive therapy systems – including Extracorporeal Magnetotransduction Therapy (EMTT) for treating musculoskeletal diseases, particularly in combination with shock wave therapy. These non-invasive therapy systems offer new options for patients and drive medical advances.
Why STORZ MEDICAL?
World-leading in shock wave therapy (ESWT/SWL)
A specialist in non-invasive therapy systems, »Made in Switzerland« since 1987.
Over 100,000 systems installed in over 130 countries
Proven in everyday clinical practice – distributed and trusted globally.
Broad range of treatment applications
Solutions for orthopaedics, sports medicine, urology, cardiology, neurology, dermatology and veterinary medicine.
Technology leader with pioneering performance
First performance of Cardiac Shock Wave Therapy (CSWT) and first treatment of patients with Alzheimer’s disease using Transcranial Pulse Stimulation (TPS).
FDA Approval for the Treatment of Kidney and Ureteral Stones in Children Aged 3 Years and Older in the USA
The MODULITH® SLX-F2 is approved in the USA by the FDA for the treatment of kidney and ureteral stones in children aged over 3 years.
Focused and radial shock wave therapy in a single shock wave device
For maximum flexibility and indication-specific application.
Integrated vibration therapy with the V-ACTOR®
For targeted muscle activation, fascial treatment and promotion of microcirculation – available as an option in our radial shock wave devices.
Approved medical technology with excellent quality
CE, FDA and MDSAP certifications for safety and clinical excellence.
Innovative EMTT – Extracorporeal Magnetotransduction Therapy
For musculoskeletal diseases – ideal in combination with radial and focused shock wave.
